Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy
Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy

Search for Research Projects and Papers

Health technology Medical Innovation HTA Early HTA Economic Evaluation Equity Carbon Footprints Greenhouse Gases Digital Health AI Telemedicine Health Promotion and Prevention
Advanced Search
Research Type
Technology and Procedure Category
Area of study
Advanced Search
Advanced search keyword
Found research "HCV" 6 Topics
Sort by
Sort by
Last updated
63231002RM 023L0
A synthesis of policy recommendations on budgeting of implementing sofosbuvir/velpatasvir as a pan-genotypic regimen for the treatment of chronic hepatitis C in Thailand
Researchers
Songyot Pilasan Pattara Leelahavarong, PhD. Disorn Kulpokin
Status
Completed
Published date
04 August 2020
Download research
icon document
0
icon arrow
Mathematical and economic modelling for optimal strategies to screen and treat chronic hepatitis C virus patients using novel antiviral agents with cost-effectiveness and budget impact analyses in Thai setting
Researchers
Dr. Wirichada Pan-ngum Kittiyod Poovorawan Waranya Rattanavipapong
Status
Completed
Published date
29 September 2018
Download research
icon document
0
icon arrow
11-3-089-2557(7)
Cost-Utility and Budget Impact Analysis of Hepatitis C Virus Treatment With Sofosbuvir-based Regimens in Thailand
Researchers
Thunyarata Anothaisintawee Waranya Rattanavipapong Songyot Pilasan
Status
Completed
Published date
17 August 2015
Download research
icon document
0
icon arrow
011-377-2556
Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in HIV Patients with Chronic Hepatitis C Co-Infection
Researchers
Kuntika Dumrongprat B.Sc. in Pharm, MIPHE Pritaporn Kingkaew, PhD.
Status
Completed
Published date
16 August 2013
Download research
icon document
0
icon arrow
011-377-2556
Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 6
Researchers
Assoc. Prof. Nattiya Kapol Surasit Lochid-amnuay Yot Teerawattananon, PhD.
Status
Completed
Published date
16 August 2013
Download research
icon document
1
icon arrow
011-377-2556
Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1
Researchers
Assoc. Prof. Nattiya Kapol Surasit Lochid-amnuay Yot Teerawattananon, PhD.
Status
Completed
Published date
16 August 2013
Download research
icon document
2
icon arrow
12 / Page